Kurs pSivida Corp. Nasdaq

Aktien

09.08.16	PSivida : Primary Endpoint Met in pSivida's Utilization Study of New Medidur™ Inserter with Smaller Diameter Needle
14.07.16	PSivida : Investigator-Sponsored Phase 2 Study Results Show pSivida's Medidur® Fully Controlled Uveitis for Two Years with No Recurrence of Disease While Visual Acuity Continued to Improve
02.05.16	PSivida : Medidur for Posterior Uveitis Granted Orphan Drug Designation in Europe
28.09.15	PSivida : Announces NDA for Medidur™ Now Planned Using Six-Month Efficacy Data from Both Phase III Trials; FDA Concurs
14.09.15	PSivida : CEO to Present at Ladenburg Thalmann 2015 Healthcare Conference September 29, 2015

1 Tag

-0.87%

Zu einer Liste hinzufügen 0 ausgewählt Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein Einloggen Anmeldung	%	% 5 Tage	Perf. 1 Jahr	Perf. 3 Jahre	Marktkap.($)
PSIVIDA CORP.	-0.87%	-2.40%	-	-	0
WUXI APPTEC CO., LTD.	-0.70%	-4.28%	+52.62%	+86.42%	71.53 Mrd.
ARGENX SE	+0.99%	+2.51%	+38.82%	+83.47%	60.12 Mrd.
WUXI BIOLOGICS (CAYMAN) INC.	+4.77%	+6.16%	+36.77%	+26.10%	27.98 Mrd.
INSMED INCORPORATED	-1.73%	-4.30%	-18.37%	+357.94%	25.25 Mrd.
BIONTECH SE	-0.51%	-2.28%	+0.48%	-9.27%	24.76 Mrd.
GENMAB A/S	+1.04%	+1.96%	+21.25%	-4.38%	20.99 Mrd.
PHARMAESSENTIA CORPORATION	+3.46%	+3.02%	+158.90%	+337.81%	15.54 Mrd.
EXELIXIS, INC.	+0.48%	+0.86%	+44.56%	+168.42%	14.53 Mrd.
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+2.96%	+0.83%	-5.25%	+519.59%	14.41 Mrd.
Durchschnitt	+1.03%	-0.79%	+36.64%	+174.01%	30.57 Mrd.
Nach Marktkapitalisierung gewichteter Durchschnitt	+0.79%	-1.52%	+36.94%	+130.24%

Beschäftigte

Sektor